Comparison of Enterprise stent 2 with 1 in assisting coiling of ruptured aneurysms: a real-world study.
J Comp Eff Res
; 11(12): 879-887, 2022 08.
Article
em En
| MEDLINE
| ID: mdl-35734978
ABSTRACT
Aim:
To investigate the effectiveness and safety of the Enterprise 2 (E2) stent versus the Enterprise 1 (E1) stent in treating ruptured intracranial aneurysms (RIAs) in China. Materials &methods:
The authors conducted an electronic medical record analysis for patients with RIAs who underwent E1/E2 deployment. The main outcomes were immediate complete occlusion (ICO), patient functional outcomes, complications and aneurysm recurrence.Results:
Stent deployment was successful in all patients (E2 90; E1 270). ICO and patients with good functional outcomes at discharge were similar between E2 and E1 (80.0% vs 75.1% and 78.7% vs 81.1%, respectively). The E2 group had a significantly lower complication rate compared with the E1 group (7.8% vs 16.4%; odds ratio 0.36; 95% CI 0.15-0.91; p = 0.031). By 6 months post-discharge, the two groups had comparable patient functional outcomes and aneurysm recurrence (E2 vs E1 80.2% vs 81.9% and 13.3% vs 14.9%).Conclusion:
Compared with the E1 stent, the E2 stent had similar effectiveness but a lower complication risk in treating RIAs.Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Aneurisma Intracraniano
/
Aneurisma Roto
/
Embolização Terapêutica
/
Procedimentos Endovasculares
Tipo de estudo:
Observational_studies
/
Risk_factors_studies
Limite:
Humans
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article